Amicus Therapeutics

With persistent unmet needs across the Pompe journey, innovative solutions to support disease diagnosis and management can create meaningful improvements in care and quality of life. Amicus Ignite is here to support and improve the lives of those impacted by Pompe disease. With up to €20,000 (or local currency equivalent) in funding available for a limited number of projects, this is your chance to make a lasting impact. Application deadline extended to 31 May 2025. To learn more or to submit an application to Amicus Ignite, please visit?https://lnkd.in/ehGECzGy. Currently, applications are only open to organisations and projects located outside of the United States. Applications for projects that relate to a particular medicinal treatment or Amicus products are?not permitted?and will?not?be funded.

La progressione della Malattia di Pompe ad esordio tardivo (LOPD) può causare una perdita irreversibile della mobilità e della funzione respiratoria, compromettendo gravemente la capacità di svolgere le attività quotidiane e, nei casi più gravi, portando a una morte prematura. Siamo un’azienda biotecnologica internazionale, dedicata ai pazienti e focalizzata sullo sviluppo e sulla fornitura di farmaci di alta qualità per le persone affette da malattie rare. Per maggiori informazioni ??: www.amicusrx.it #AmicusTherapeutics #MalattiadiPompe #malattierare

In honor of #RareDiseaseDay, Team Amicus was joined by some of our #FabryDisease and #PompeDisease Champions for our annual Rare Disease Day Global Lunch & Learn – Tiffany Patrick, MPH, MBA moderated an exploration of this year’s theme, “More Than You Can Imagine” and what this means for these rare disease community leaders. Several of our patient champions from the U.S. and the UK shared their unique experiences, including George, a proud father and primary caregiver of his son, Phoenix, who lives with Pompe disease. “I have gained more than I could have imagined – a deeper appreciation for the little moments and a greater understanding of what truly matters – love, resilience and connections we build along the way.” George shared his family’s journey, highlighting his favorite moments with Phoenix, the vital role of resources and medical technology, and the importance of ensuring every person living with a rare disease gets the care, access, and support they deserve. For George and Phoenix, a diagnosis changed their family’s path, but it didn’t take away their ability to build a joyful, fulfilling life. At Amicus, being a patient-first company means amplifying the voices of those living with rare diseases and internalizing their stories as a guiding light for everything we do. Our dedication to patients and their families is what drives us to truly provide healing beyond disease. Learn more here: https://lnkd.in/gvjs96ZV #RareDiseaseDay #PatientAdvocacy #AmicusCares

With the vital help of our patient community partners, we are thrilled to see our study published emphasizing the importance of understanding the quality of life and lived experiences of those with late-onset Pompe disease (#LOPD). https://bit.ly/3R0g18W

In honor of #InternationalWomensDay, we welcomed Nomi Network to shed light on the Network's important work to end human trafficking by creating pathways to safe employment, empowering women and girls to break cycles of exploitation in their families and communities. #IWD2025 #AmicusCares #Equality

For 20 years, one of our guiding founding beliefs has been, "We believe in each other to foster teamwork and respect for each individual's contribution." Today, in recognition of International Women’s Day, we celebrate and extend our gratitude to our incredible women senior leaders and women all throughout our global organization. Their unwavering dedication and exceptional leadership have been integral to establishing Amicus as a truly unique rare disease company. #IWD2025 #WomeninLeadership #AmicusCares

At Amicus, all people living with rare diseases are the inspiration behind our mission to develop and deliver transformative medicines for people living with rare diseases. On International Women's Day, we want to take this moment to honor and thank the brave and resilient women who are living with rare diseases or caring for someone with a rare disease. Learn more about some of their inspiring stories here: https://bit.ly/41sogQ3 #IWD2025 #Diversity #RareDisease #AmicusCares

This week, Paul Howard, PhD, Executive Director, Policy and Patient Experience Innovation?at Amicus, attended the EveryLife Foundation for Rare Diseases' Legislative Conference for Rare Disease Week. Together with EveryLife Foundation’s CEO, Michael Pearlmutter, Paul was joined by two #FabryDisease and #PompeDisease Patient Champions, Darrick and Heather. The conference — taking place just prior to #RareDiseaseDay — was a powerful reminder of the collective strength of those advocating for the rare disease community. Hundreds of rare disease advocates gathered to raise awareness, share their stories, and make their voices heard by policymakers. We were honored to join them and to express our unwavering support for those living with rare diseases. #EveryLifeFoundation #AmicusCares?

Today, on Rare Disease Day, it is time to reflect, raise awareness, and stand with the rare disease community. Read more from Jayne Gershkowitz, Chief Patient Advocate, on what this day means and how we can all make an impact??? #RareDiseaseDay #MoreThanYouCanImagine #RareDiseaseAdvocacy

On #RareDiseaseDay, we stand in solidarity with the 300 million people around the world living with rare diseases and those who care for them. As a company founded 20 years ago to help people living with rare diseases, we applaud the progress that has been made and are excited about what’s yet to come.?Help us spread awareness by showing your support! Together, we can make a difference for people living with rare diseases. Learn more about one of our patient heroes, Lisa, who is living with Fabry disease:?https://bit.ly/3Xk9Kss #AmicusCares #RareDiseaseDay #MoreThanYouCanImagine